Table 1 Clinical characteristics of EGFR-mutation harboring NSCLC patients enrolled in HOPE project.

From: Localization of epidermal growth factor receptor-mutations using PNA:DNA probes in clinical specimens from patients with non-small cell lung cancer

EGFR mutations

Case No

Age*

Sex#

Tumor content (%)

VAF (%)

Pathology

Survival+ (month)

L858R

11

65

3/8

36.7

35.3

AC 10, AC + LCNEC 1

50.3

Exon19 deletion

9

66

1/8

29.2

31.7

AC 9

57.2

None

11

65

7/3

36.0

NA

AC 6, SCC 3, ACC 1

53.3

  1. AC adenocarcinoma, SCC squamous cell carcinoma, ACC adenoid cystic carcinoma, NA not available.
  2. *Age: mean value.
  3. #Male/female number.
  4.  + Mean overall survival time in days.
Back to article page